ADVERTISEMENT
Manila Bulletin devider Philippines devider National devider Suspected mpox case in BARMM found to be negative, says DOH chief

Suspected mpox case in BARMM found to be negative, says DOH chief

Published Nov 25, 2024 08:41 am

Department of Health (DOH) Secretary Teodoro Herbosa confirmed on Monday, Nov. 25 that a suspected case of monkeypox (mpox) in the Bangsamoro Autonomous Region in Muslim Mindanao (BARMM) has tested negative for the virus.

In a televised public briefing, Herbosa shared the “good news” after receiving the results from the Research Institute for Tropical Medicine (RITM).

“I just received this morning the good news. Negative po for monkeypox iyong suspect case natin sa BARMM, sa Lanao. Natala noong weekend, na sabi ko, hindi pa final iyan and true enough, this morning lumabas na iyong result ng RITM (The suspected mpox case in BARMM, in Lanao, tested negative for monkeypox. It was recorded over the weekend, and as I mentioned earlier, the result was not final yet. And true enough, this morning, the RITM result came out),” he said.

The suspected case had been under observation after showing symptoms that could potentially be linked to monkeypox. However, Herbosa clarified that it was likely another viral or skin disease.

“Hindi po monkeypox, malamang ibang illness iyon o ibang viral illness or skin disease iyong nakita doon sa BARMM (It’s not monkeypox, most likely another illness or a different viral or skin disease observed in BARMM),” he added.

Meanwhile, Herbosa said the DOH still awaits the results of two other suspected mpox cases from Quezon City and Calabarzon.

He reassured the public about the current status of mpox in the country, saying that no cases of the clade 1b variant, linked to the international health emergency in Africa, have been detected in the Philippines.

He also pointed out that the DOH has significantly managed the monkeypox cases.

Of the approximately 50 reported cases in the country, 17 have fully recovered, and the remaining active cases are expected to recover soon.

“Iyong mga monkeypox, ito iyong mga self-limiting or gumagaling kaagad (Monkeypox is a self-limiting illness, meaning people recover quickly),” he said.

Herbosa also announced that the government has procured Tecovirimat, an antiviral medication used to treat monkeypox, particularly for patients who also have HIV.

He explained that the antiviral treatment will be crucial for people living with HIV who contract monkeypox, as this group is at higher risk of severe symptoms.

READ MORE: https://mb.com.ph/2024/8/13/doh-on-alert-following-mpox-emergency-declaration-in-africa

Related Tags

Department of Health (DOH) Secretary Teodoro Herbosa Mpox
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ item.title }}

{{ articles_filter_1564_widget.title }}

{{ item.title }}
.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });
Join Our Newsletters

Sign up by email to receive news.

© 2025 Manila Bulletin The Nation's Leading Newspaper. All Rights Reserved.